MBOT Stock Chart & Stats
$2.34
-$1.10(-38.87%)
At close: 4:00 PM EST
$2.34
-$1.10(-38.87%)
Day’s Range― - ―
52-Week Range$1.60 - $4.67
Previous CloseN/A
Volume6.51M
Average Volume (3M)1.68M
Market Cap
$128.28M
Enterprise Value$82.91M
Total Cash (Recent Filing)$72.50M
Total Debt (Recent Filing)$898.00K
Price to Earnings (P/E)―
Beta1.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding67,164,800
10 Day Avg. Volume851,924
30 Day Avg. Volume1,678,929
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.18
Price to Sales (P/S)0.00
P/FCF Ratio-6.99
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue789.65
Enterprise Value/Gross Profit-8.29K
Enterprise Value/Ebitda-5.85
Forecast
1Y Price Target
$7.17Price Target Upside206.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.31
Revenue Forecast (FY)$5.10M
Bulls Say, Bears Say
Bulls Say
Clinical Validation And Reference CustomersAdoption by prominent centers such as Emory University Hospital and Tampa General Hospital offers clinical validation that could encourage other health systems to evaluate the platform.
Commercial Adoption PaceRapid customer uptake during the limited release across multiple procedure types indicates a potentially shorter sales cycle versus traditional surgical robots, supporting faster commercial momentum if scaled.
Regulatory PositioningFDA clearance as a single-use remotely operated robotic system provides a distinct regulatory and product advantage that can strengthen market differentiation in peripheral endovascular procedures.
Bears Say
Financing And Dilution RiskNegative cash flow increases the probability of future capital raises, which could dilute existing investors if additional funding is required.
Liquidity And Runway UncertaintyAvailable cash resources may be insufficient to sustain an aggressive commercial rollout without securing further financing, introducing uncertainty around the company’s runway.
Operating LossesOngoing operating losses and negative cash flow from operations create financial pressure that may constrain flexibility in executing growth plans.
Microbot Medical News
MBOT FAQ
What was Microbot Medical’s price range in the past 12 months?
Microbot Medical lowest stock price was $1.60 and its highest was $4.67 in the past 12 months.
What is Microbot Medical’s market cap?
Microbot Medical’s market cap is $128.28M.
When is Microbot Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Microbot Medical’s earnings last quarter?
Currently, no data Available
Is Microbot Medical overvalued?
According to Wall Street analysts Microbot Medical’s price is currently Undervalued.
Does Microbot Medical pay dividends?
Microbot Medical does not currently pay dividends.
What is Microbot Medical’s EPS estimate?
Microbot Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbot Medical have?
Microbot Medical has 67,164,800 shares outstanding.
What happened to Microbot Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Microbot Medical?
Currently, no hedge funds are holding shares in MBOT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Microbot Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.17 (206.27% Upside)
$7.17 (206.27% Upside)
Blogger Sentiment
Neutral
MBOT Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 16.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 3.0%
Last 30 Days ▼ 3.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.60%
12-Months-Change
Fundamentals
Return on Equity
-21.84%
Trailing 12-Months
Asset Growth
152.71%
Trailing 12-Months
Company Description
Microbot Medical
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
MBOT Stock 12 Month Forecast
Average Price Target
$7.17
▲(206.27% Upside)
Technical Analysis
Ownership Overview
0.20%
Insiders
5.85% Mutual Funds
2.27% Other Institutional Investors
86.86% Public Companies and
Individual Investors